Emergency contraception and the FDA
February 10, 2011 § 2 Comments
The Center sued the FDA in 2005 for failing to grant over-the-counter status to emergency contraception (a.k.a Plan B) against the advice of its scientific experts and in violation of its own procedures and regulations. In 2006, the FDA agreed to make Plan B available without a prescription, but only to women 18 and over and only behind the pharmacy counter.
Plan B is now available over-the-counter for anyone age 17 or over, but remains inaccessible to those under 17 even though “medical and scientific consensus provides no rationale for age restrictions on Plan B.”
Today, emergency contraception is available without a prescription, but only for women age 17 and older. Pharmacies and clinics must keep it behind the counter and anyone seeking to buy it must show government issued identification proving their age in order to buy it without a prescription.
These intrusive restrictions, unprecedented for drugs with over-the-counter status, make it harder and more stigmatizing for consumers to get the contraception during its most effective window.
These restrictions are undeniably motivated by political and social pressures that seek to legislate sexuality. (I’ll quote myself: “It’s more than obvious that the conservative movement to restrict access is not about the health and safety of teenage women, but about legislating who is and isn’t allowed to have sex.”) Never mind that the political leaders who restrict Plan B access, which prevents conception after unprotected sex, are the same people who restrict abortion access — abortion being what women might logically turn to when faced with an unplanned pregnancy that using Plan B might have prevented in the first place.
But this morning brought some good news:
Moments ago, Teva, the manufacturer of the emergency contraceptive (EC) Plan B, announced that it filed an application with the FDA requesting that EC be available over-the-counter without a prescription for women of all ages.
While it’s phenomenal that Teva has put this pressure on the FDA, their request will only affect restrictions on their specific emergency contraception product. In an email, the Center for Reproductive Rights emphasized: “We want the FDA to know that it is still required to obey the law and end all restrictions once and for all –- not on a piece meal basis.”